drugset
drugset / Trial / NCT01572324

Study of Hepatic Arterial Infusion to Treat Biliary Tract Carcinomas

NCT01572324 ↗

Phase 2 Completed 37 enrolled Peking University
NaSingle-groupOpen-labelTreatment

Summary

This Phase II clinical trial is to study the effectiveness and safety of continuous hepatic arterial infusion (HAI) of Oxaliplatin and Fluorouracil in Patients with Unresectable Biliary tract carcinomas, and to explore a better first-line treatment regimen for these patients.

Timeline

Start
2012-03
Primary completion
2015-10
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Capecitabine Small molecule 1000 mg/m2 Oral
Subject Oxaliplatin Small molecule 130 mg/m2 Other
Subject fluorouracil Small molecule 3000 mg/m2 Other
Background Leucovorin Small molecule 200 mg/m2 Intravenous

Indications

biliary tract cancer